ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 131 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,147,883 | -61.4% | 1,771,279 | -45.8% | 0.01% | -50.0% |
| Q2 2023 | $21,108,812 | +185700.7% | 3,267,618 | +116.9% | 0.01% | +66.7% |
| Q1 2023 | $11,361 | +90.6% | 1,506,698 | +156.0% | 0.01% | +100.0% |
| Q4 2022 | $5,961 | -99.9% | 588,448 | -49.7% | 0.00% | -57.1% |
| Q3 2022 | $11,564,000 | -66.6% | 1,169,304 | -64.1% | 0.01% | -68.2% |
| Q2 2022 | $34,653,000 | +137.9% | 3,253,844 | +117.8% | 0.02% | +175.0% |
| Q1 2022 | $14,566,000 | +46.3% | 1,493,996 | +114.5% | 0.01% | +60.0% |
| Q4 2021 | $9,958,000 | -41.4% | 696,361 | -17.9% | 0.01% | -50.0% |
| Q3 2021 | $16,990,000 | +1076.6% | 847,819 | +1191.3% | 0.01% | +900.0% |
| Q2 2021 | $1,444,000 | +74.4% | 65,657 | +169.2% | 0.00% | 0.0% |
| Q1 2021 | $828,000 | -78.7% | 24,388 | -74.7% | 0.00% | -66.7% |
| Q4 2020 | $3,885,000 | – | 96,556 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |